Dianhydrogalactitol (VAL-083) reduces glioblastoma tumor growth upon bevacizumab-induced hypoxia, in vivo

Golebiewska, A; Oudin, A; Steino, A; Niclou, SP; Bacha, J; Brown, DM

CANCER RESEARCH, 2019; 79 (13):